• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

追踪肝硬化患者肾功能不全的轨迹:急性肾损伤-慢性肾病谱

Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury: chronic kidney disease spectrum.

作者信息

Girish Vishnu, Maiwall Rakhi

机构信息

Department of Hepatology, Institute of Liver and Biliary Sciences, Delhi, India.

出版信息

Clin Mol Hepatol. 2025 Jul;31(3):730-752. doi: 10.3350/cmh.2024.1060. Epub 2025 Mar 26.

DOI:10.3350/cmh.2024.1060
PMID:40138802
Abstract

Kidney disease in cirrhosis is now viewed as a continuum encompassing acute kidney injury (AKI), acute kidney disease (AKD), and chronic kidney disease (CKD), rather than three different disorders. Contemporary diagnostic criteria for AKI integrate urine output (UO) parameters and acknowledge the intricate relationship and possibility of overlap between functional and structural as well as acute and chronic entities, including hepatorenal syndrome (HRS). AKI demonstrates a propensity for progression to AKD and CKD, particularly in the context of recurrent and severe insults. The diagnostic complexity is further compounded by limitations in serum creatinine measurements, prompting the integration of novel biomarkers and the need to accurately estimate glomerular filtration rate. The diagnosis, phenotyping, and management of AKI should be prompt and early; the initial step should always be volume and UO assessment. A personalized approach is needed and the possibility of co-existing structural or functional kidney disease should be borne in mind. The earlier concept of waiting for 48 hours to diagnose HRS has evolved and early diagnosis and prompt treatment are advised now. Kidney replacement therapy and simultaneous liver and kidney transplantation may be required in resistant cases.

摘要

肝硬化中的肾脏疾病现在被视为一个连续统一体,涵盖急性肾损伤(AKI)、急性肾病(AKD)和慢性肾病(CKD),而不是三种不同的疾病。AKI的当代诊断标准整合了尿量(UO)参数,并认识到功能和结构以及急性和慢性实体(包括肝肾综合征(HRS))之间的复杂关系和重叠可能性。AKI有发展为AKD和CKD的倾向,特别是在反复和严重损伤的情况下。血清肌酐测量的局限性进一步加剧了诊断的复杂性,促使人们采用新的生物标志物并准确估计肾小球滤过率。AKI的诊断、表型分析和管理应迅速且早期进行;第一步应始终是评估血容量和尿量。需要采用个性化方法,并应考虑到并存结构性或功能性肾脏疾病的可能性。等待48小时诊断HRS的早期概念已经演变,现在建议早期诊断和及时治疗。难治性病例可能需要肾脏替代治疗以及同期肝肾移植。

相似文献

1
Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury: chronic kidney disease spectrum.追踪肝硬化患者肾功能不全的轨迹:急性肾损伤-慢性肾病谱
Clin Mol Hepatol. 2025 Jul;31(3):730-752. doi: 10.3350/cmh.2024.1060. Epub 2025 Mar 26.
2
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
3
Distribution of Acute and Chronic Kidney Disease Across Clinical Phenotypes for Sepsis.脓毒症急性和慢性肾脏病在各临床表型中的分布情况
Chest. 2024 Sep;166(3):480-490. doi: 10.1016/j.chest.2024.03.006. Epub 2024 Mar 8.
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences.中性粒细胞明胶酶相关脂质运载蛋白 (NGAL) 作为急性肾损伤的生物标志物:实验室特征和临床证据的综述。
Clin Chem Lab Med. 2012 Feb 15;50(9):1505-17. doi: 10.1515/cclm-2011-0814.
6
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.羟乙基淀粉(HES)与其他液体疗法:对肾功能的影响。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD007594. doi: 10.1002/14651858.CD007594.pub3.
7
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
8
The Effect of Positive Pressure Ventilation on Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: An Observational Study.正压通气对 COVID-19 合并急性呼吸窘迫综合征患者急性肾损伤的影响:一项观察性研究。
Blood Purif. 2024;53(5):396-404. doi: 10.1159/000536285. Epub 2024 Feb 25.
9
Beckwith-Wiedemann Syndrome贝克威思-维德曼综合征
10
Overview and management of hepatorenal syndrome.肝肾综合征的概述与管理
Curr Opin Anaesthesiol. 2025 Aug 1;38(4):492-497. doi: 10.1097/ACO.0000000000001526. Epub 2025 Jun 17.

本文引用的文献

1
AKI in ACLF: navigating the complex therapeutic puzzle.急性肾损伤在慢加急性肝衰竭中:应对复杂的治疗难题。
Expert Rev Gastroenterol Hepatol. 2025 Jan-Feb;19(2):165-180. doi: 10.1080/17474124.2025.2456121. Epub 2025 Jan 23.
2
AARC score and urine NGAL predict terlipressin non-response and mortality in patients with acute-on-chronic liver failure.AARC评分和尿中性粒细胞明胶酶相关脂质运载蛋白可预测慢加急性肝衰竭患者对特利加压素无反应及死亡率。
Hepatol Int. 2025 Feb;19(1):222-233. doi: 10.1007/s12072-024-10749-4. Epub 2024 Nov 28.
3
Editorial: Solving the acute kidney injury puzzle in alcohol-associated hepatitis-Challenges and insights.
社论:解决酒精性肝炎中的急性肾损伤难题——挑战与见解
Aliment Pharmacol Ther. 2024 Oct;60(7):963-964. doi: 10.1111/apt.18206. Epub 2024 Sep 3.
4
Role of point-of-care ultrasound (POCUS) in clinical hepatology.床旁超声(POCUS)在临床肝病学中的作用。
Hepatology. 2024 Jul 1. doi: 10.1097/HEP.0000000000000990.
5
The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia.沙特阿拉伯代谢功能障碍相关脂肪性肝病和病毒性肝炎的负担。
Saudi J Gastroenterol. 2024 Sep 1;30(5):310-318. doi: 10.4103/sjg.sjg_62_24. Epub 2024 Jun 28.
6
APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure.亚太肝脏研究学会急性失代偿期肝衰竭相关急性肾损伤管理临床实践指南。
Hepatol Int. 2024 Jun;18(3):833-869. doi: 10.1007/s12072-024-10650-0. Epub 2024 Apr 5.
7
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting.肝硬化患者的急性肾损伤:急性疾病质量倡议 (ADQI) 和国际腹水俱乐部 (ICA) 联合多学科共识会议。
J Hepatol. 2024 Jul;81(1):163-183. doi: 10.1016/j.jhep.2024.03.031. Epub 2024 Mar 26.
8
Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.前瞻性验证 EASL 肝硬化急性肾损伤管理算法。
J Hepatol. 2024 Sep;81(3):441-450. doi: 10.1016/j.jhep.2024.03.006. Epub 2024 Mar 11.
9
AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis.美国肝病研究学会关于慢加急性肝衰竭及肝硬化危重症患者管理的实践指南。
Hepatology. 2024 Jun 1;79(6):1463-1502. doi: 10.1097/HEP.0000000000000671. Epub 2023 Nov 9.
10
A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis.一项评估肝硬化患者造影剂诱导的急性肾损伤(CI-AKI)的前瞻性、多中心、三队列研究。
J Hepatol. 2024 Jan;80(1):62-72. doi: 10.1016/j.jhep.2023.10.010. Epub 2023 Oct 20.